Patients with COPD Benefit from Inhaled CorticosteroidsAccording to a new study published in the CHEST, a peer-reviewed journal of the American College of Chest Physicians (ACCP), patients with COPD (Chronic obstructive pulmonary disease) who use inhaled corticosteroids are believed to have a decreased mortality risk.

Christine Macie, MD, FCCP, Cambridge Hospital, Ontario, Canada and author of this study, remarked that the survival is longer in COPD patients who make use of inhaled corticosteroids.

Dr. Macie also remarked that patients who are using inhaled corticosteroids are relatively better protected than those not using it.

It was found during the study that patients receiving inhaled corticosteroids within thirty days of discharge from the hospital had a 25% reduced all-cause mortality rate. Furthermore, cardiovascular related deaths were reduced by as much as 38% in patients using corticosteroids paired with beta-agonists.